Model N, Inc. provides revenue management cloud solutions for the life sciences and high tech industries. The company offers Global Pricing Management, which minimizes price erosion of products; Global Tender Management that enhances revenue by enabling segmentation and targeting, optimal bid pricing, and post-award tracking; Provider Management, which minimizes rebate overpayments; Payer Management that minimizes revenue leakage and noncompliance of complex contracts; Government Pricing, which optimizes revenue, and reduces the risk of fines and other penalties; and Medicaid that enhances compliance with regulatory requirements and payments of rebate claims timely, as well as at correct rates for government medicaid programs. It also provides Deal Management, which increases deal conversion and pricing consistency; Deal Intelligence that controls price concessions and determines ideal prices; Channel Management, which provides manufacturers a view of inventory, as well as evaluate price protection and stock rotation, and matching available inventory to quotes; Market Development Fund Management that allows companies to streamline their MDF process and reduce revenue leakage; and Rebates Management, which centralizes control of rebate programs. In addition, the company offers Channel Data Management that automates the process of collection, cleansing, validation, and standardization of channel partner data, such as POS, inventory, and claims; and Configure Price Quote, which streamlines the quote to contract process by enabling the configuration of complex services, bundles, and solutions into a single interface; and Contract Lifecycle Management that enables users to create and manage contracts directly. Further, it provides implementation, managed, strategic, and customer support services. It primarily serves large and mid-sized organizations worldwide through its direct sales force. Model N, Inc. was founded in 1999 and is headquartered in San Mateo, California.
IPO Year: 2013
Exchange: NYSE
Website: modeln.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/7/2024 | Mkt Outperform → Mkt Perform | JMP Securities | |
| 12/13/2023 | $30.00 → $25.00 | Overweight → Neutral | JP Morgan |
| 11/10/2023 | Buy → Neutral | BTIG Research | |
| 7/12/2023 | $40.00 | Hold | Jefferies |
| 7/6/2023 | $45.00 | Buy | Goldman |
| 4/27/2023 | $35.00 | Sector Perform | RBC Capital Mkts |
| 3/27/2023 | $43.00 | Overweight | Morgan Stanley |
| 2/9/2022 | $45.00 → $34.00 | Buy | Needham |
| 12/14/2021 | $38.00 | Neutral → Overweight | JP Morgan |
| 11/10/2021 | $50.00 → $45.00 | Buy | Needham |